Walter K K Ho

Title: Walter K K Ho: Innovator in Malaria Vaccine Development

Introduction

Walter K K Ho is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of immunology, particularly in the development of malaria vaccines. His innovative approach utilizes the silkworm/baculovirus system to produce recombinant proteins that can aid in malaria prevention.

Latest Patents

Walter K K Ho holds a patent for a "Malaria immunogenic composition." This invention focuses on the production of recombinant Major Merozoite Surface Protein 1 (MSP1) using a cost-effective and high-yield expression system. The MSP1 (3D7 sequence) was successfully cloned into the baculovirus, BmNPV, which was then used to infect silkworms for the expression of MSP1 (Sp42). The results demonstrated that one recombinant clone expressed a high level of Sp42, producing an estimated 0.5 mg of antigen per worm. The Sp42 was recognized by specific antibodies, indicating its potential as an effective malaria vaccine candidate.

Career Highlights

Walter K K Ho's career is marked by his dedication to advancing vaccine technology. His work has shown that the silkworm expression system can produce recombinant MSP1 that is antigenically and immunogenically comparable to other systems. This innovation presents a promising alternative for developing a human malaria vaccine, emphasizing both low cost and high protein expression levels.

Collaborations

Walter has collaborated with notable colleagues, including George S N Hui and Lap-Yin Pang. Their combined expertise has contributed to the success of his research and the advancement of malaria vaccine development.

Conclusion

Walter K K Ho's innovative work in the field of malaria immunology highlights the potential of using alternative expression systems for vaccine development. His contributions are paving the way for more effective and accessible malaria prevention strategies.